Yseop

Name

Yseop

Legal name

YSEOP

Website

https://yseop.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Life Sciences AI Software

NAICS

Custom Computer Programming Services (541511), Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)

akta.pro industry

PRIMARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAGAOAB

Data Management, Biostatistics & Statistical Programming FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

• Regulatory document automation
• Natural language generation
• Clinical writing software
• Pharma AI software
• Medical writing automation

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Yseop Copilot Platform Subscription: SaaS platform subscription for regulatory and medical writing automation. Enterprise licensing model with pricing based on document volume, users, and automation pack selections. Includes platform access, support, and continuous updates.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Yseop builds and sells Yseop Copilot, an AI-powered enterprise SaaS platform that automates the generation of regulatory and clinical documents (clinical study reports, patient narratives, safety reports, preclinical and CMC submissions) for pharmaceutical and life sciences customers. The platform is built on a neuro-symbolic AI architecture combining LLMs with symbolic reasoning and deterministic RAG to produce traceable, validated, audit-ready text. The company also sells the Augmented Analyst platform for financial and performance reporting, deployed by enterprises such as L'Oréal, with applications including the Augmented Medical Writer and Augmented Financial Analyst.

Product overview

Yseop is a B2B AI software company offering a unified platform portfolio centered on Yseop Copilot and the Augmented Analyst platform. Yseop Copilot is the primary enterprise platform for life sciences companies, providing AI-powered document automation with neuro-symbolic AI architecture for regulatory-grade reliability. The Augmented Analyst platform serves both life sciences and financial services, supporting Augmented Medical Writer and Augmented Financial Analyst applications. The platform operates through modular automation packs including Clinical Study Report (CSR), Patient Narrative, Summary Clinical Safety, Preclinical Study Report, and Quality Overall Summary (QOS) automation for regulatory submissions. Business Intelligence Report Automation extends capabilities to enterprise BI tools. All products emphasize traceability, compliance, and human control in regulated environments.

Differentiator

Problem solved

Functional benefit

Brands

• Yseop Copilot: AI-powered platform that acts as a digital colleague for scientific writers, enabling automation of regulatory and clinical document generation with full traceability and compliance.
• Augmented Analyst
• Augmented Medical Writer

Products and services

• Yseop Copilot Primary enterprise AI platform for life sciences that automates regulatory and clinical document generation workflows (CSRs, patient narratives, SCS, preclinical and CMC/QOS submissions) with full traceability, GxP-compliant audit trail, and human-in-the-loop approval. Built on a neuro-symbolic AI architecture combining LLMs with symbolic reasoning and deterministic RAG, with native integrations into Microsoft Word and Veeva Vault RIM.
• Augmented Analyst AI-powered NLP platform that analyzes enterprise data and delivers automated insight and document generation across financial, performance, credit risk, and BI reporting use cases. Comprises applications including the Augmented Medical Writer and Augmented Financial Analyst and integrates directly with BI tools such as Tableau, Qlik, and Power BI to turn structured data into written narratives.

Quantifiable outcome

• Less than 7% of content requires re-authoring (validated against regulatory rules)
• +5 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability8 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Veeva SystemscoreTechnology or Integration · 5 September 2024Yseop joined Veeva's AI Partner Program. Yseop Copilot integrates with Veeva Vault RIM for single-click document generation in medical writing. The partnership enables mutual life sciences customers to improve visibility, data quality, and agility in regulatory document workflows.
• Amazon Web Services (AWS)coreTechnology or Integration · 1 May 2024AWS provides Yseop's cloud infrastructure, security, and scalability. Yseop leverages AWS services including Amazon Sagemaker, Amazon Bedrock, Amazon EKS, Amazon RDS, AWS Inferentia, and EC2 for its LLM ecosystem and AI capabilities. AWS partnership enables enterprise-grade security, data localization compliance, and access to advanced AI capabilities within a fully managed private cloud environment.
• CognizantminorImplementation/ SI/ Consulting PartnerCognizant and Yseop announced a partnership to scale medical writing through generative AI. Cognizant's AI and industry expertise combined with Yseop's platform aims to improve productivity of scientific writers across the life sciences value chain.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Automated Insights: Automated Insights (Wordsmith platform) pioneered NLG for automated report generation across business intelligence, finance, and other data-driven verticals. Directly comparable to Yseop's Augmented Analyst for automated narrative generation from structured data.
• Arria NLG: Arria NLG is a direct competitor offering Natural Language Generation technology that converts structured data into written narratives for enterprise reporting, financial services, and life sciences. It is the closest comparable in pure NLG technology to Yseop's core competency.

Emerging players

• Saama Technologies: Saama provides AI-driven clinical trial analytics and lifecycle management technology for pharma, including patient narrative and CSR-adjacent capabilities. Comparable as an emerging AI platform targeting pharma clinical operations with similar buyer personas.
• Deep 6 AI: Deep 6 AI uses AI to mine clinical trial data and accelerate patient recruitment and trial operations. Adjacent AI-for-clinical-trials vendor with overlap in pharma R&D AI tooling, though focused on trial feasibility rather than document generation.
• Mendel: Mendel applies AI/ML to structure clinical and medical record data for pharma R&D and clinical trial use cases. Comparable as an emerging AI-native vendor serving pharma with NLP-driven document/data intelligence, though focused on upstream data structuring rather than regulatory document generation.

Broad incumbents

• IQVIA: IQVIA is the largest CRO with deep technology capabilities including Linguamatics NLP and a clinical analytics platform. Operates adjacent to Yseop in pharma R&D IT and competes for similar budget allocations from pharma medical-writing and regulatory affairs teams.
• OpenAI: OpenAI provides the underlying LLM technology used by many generative AI platforms and is rapidly building enterprise compliance, retrieval, and audit features that compete with specialized NLG vendors like Yseop. Threatens Yseop's differentiation as generic LLMs become more reliable for regulated use cases.
• Narrative Science (Salesforce): Narrative Science pioneered NLG for BI dashboards (Tableau, Power BI) and was acquired by Salesforce to bring natural language narratives into the CRM/analytics stack. Comparable to Yseop's BI report automation extensions for Tableau, Qlik, and Power BI, but now embedded within the Salesforce ecosystem.
• Veeva Systems: Veeva is Yseop's primary channel partner (AI Partner Program) but also a potential competitor with its own Vault platform and AI roadmap for regulatory content management. Veeva owns the workflow; Yseop plugs into it — making Veeva both essential partner and existential risk.
• Microsoft (Copilot / Microsoft 365): Microsoft is Yseop's integration partner (Word) but also the broadest incumbent threat: Microsoft 365 Copilot and Azure OpenAI Service are rapidly improving on enterprise compliance and grounding features and could be deployed as alternative regulatory-writing tools inside pharma IT environments.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/YseopAI
• YouTubeyoutube.com/channel/UC7d4tbF8ORis2edN3ygPf1g
• LinkedInlinkedin.com/company/yseop
• Facebookfacebook.com/YseopAI

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yseop